- Home
- RNGR vs CERS Comparison
RNGR vs CERS Comparison
Compare RNGR & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNGR
- CERS
- Stock Information
- Founded
- RNGR 2017
- CERS 1991
- Country
- RNGR United States
- CERS United States
- Employees
- RNGR N/A
- CERS N/A
- Industry
- RNGR Oilfield Services/Equipment
- CERS EDP Services
- Sector
- RNGR Energy
- CERS Technology
- Exchange
- RNGR Nasdaq
- CERS Nasdaq
- Market Cap
- RNGR 274.0M
- CERS 324.3M
- IPO Year
- RNGR 2017
- CERS 1997
- Fundamental
- Price
- RNGR $15.07
- CERS $1.72
- Analyst Decision
- RNGR Hold
- CERS Buy
- Analyst Count
- RNGR 2
- CERS 3
- Target Price
- RNGR $12.50
- CERS $3.17
- AVG Volume (30 Days)
- RNGR 133.3K
- CERS 2.0M
- Earning Date
- RNGR 10-28-2024
- CERS 10-30-2024
- Dividend Yield
- RNGR 1.32%
- CERS N/A
- EPS Growth
- RNGR N/A
- CERS N/A
- EPS
- RNGR 0.63
- CERS N/A
- Revenue
- RNGR $579,500,000.00
- CERS $176,229,000.00
- Revenue This Year
- RNGR N/A
- CERS $26.47
- Revenue Next Year
- RNGR $12.00
- CERS $11.48
- P/E Ratio
- RNGR $23.95
- CERS N/A
- Revenue Growth
- RNGR N/A
- CERS 14.71
- 52 Week Low
- RNGR $9.27
- CERS $1.38
- 52 Week High
- RNGR $15.58
- CERS $2.59
- Technical
- Relative Strength Index (RSI)
- RNGR 76.25
- CERS 47.71
- Support Level
- RNGR $14.86
- CERS $1.59
- Resistance Level
- RNGR $15.58
- CERS $2.03
- Average True Range (ATR)
- RNGR 0.47
- CERS 0.14
- MACD
- RNGR 0.14
- CERS 0.02
- Stochastic Oscillator
- RNGR 83.79
- CERS 39.22
About RNGR Ranger Energy Services Inc.
Ranger Energy Services Inc is a provider of onshore high specification (high-spec) well service rigs, wireline services, and additional processing solutions and ancillary services in the United States. It offers a range of well site services to U.S. exploration and production (E&P) companies that are fundamental to establishing and enhancing the flow of oil and natural gas throughout the productive life of a well. The segments of the group are High Specification Rigs, Wireline Services and Processing Solutions and Ancillary Services, of which key revenue is derived from High Specification Rigs segment.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.